110 related articles for article (PubMed ID: 25788217)
1. Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists.
Braam HJ; Boerma D; Wiezer MJ; van Ramshorst B
Int J Clin Oncol; 2015 Oct; 20(5):928-34. PubMed ID: 25788217
[TBL] [Abstract][Full Text] [Related]
2. Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC.
Iavazzo C; Fotiou A; Tsiatas M; Christopoulou A; Spiliotis J; Sugarbaker P
Pleura Peritoneum; 2020 Mar; 5(1):20190029. PubMed ID: 32821775
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer.
Chand M; Swift RI; Chau I; Heald RJ; Tekkis PP; Brown G
Ann R Coll Surg Engl; 2014 Oct; 96(7):543-6. PubMed ID: 25245736
[TBL] [Abstract][Full Text] [Related]
4. Differential Perspectives by Specialty on Oligometastatic Colorectal Cancer: A Korean Oligometastasis Working Group's Comparative Survey Study.
Cho WK; Yoo GS; Rim CH; Jeong JU; Chie EK; Ahn YC; Cho HM; Um JW; Suh YG; Chang AR; Lee JH;
Cancer Res Treat; 2023 Oct; 55(4):1281-1290. PubMed ID: 37290481
[TBL] [Abstract][Full Text] [Related]
5. Authors' Response to the Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".
Khaled C; El Asmar A; Liberale G
Ann Surg Oncol; 2023 Nov; 30(12):7643-7644. PubMed ID: 37620538
[No Abstract] [Full Text] [Related]
6. Oncologists' experiences with drug shortages.
Kehl KL; Gray SW; Kim B; Kahn KL; Haggstrom D; Roudier M; Keating NL
J Oncol Pract; 2015 Mar; 11(2):e154-62. PubMed ID: 25549653
[TBL] [Abstract][Full Text] [Related]
7. Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018.
Le DM; Ahmed S; Ahmed S; Brunet B; Davies J; Doll C; Ferguson M; Ginther N; Gordon V; Hamilton T; Hebbard P; Helewa R; Kim CA; Lee-Ying R; Lim H; Loree JM; McGhie JP; Mulder K; Park J; Renouf D; Wong RPW; Zaidi A; Asif T
Curr Oncol; 2019 Dec; 26(6):e773-e784. PubMed ID: 31896948
[TBL] [Abstract][Full Text] [Related]
8. HIPECT4 Trial-the Devil Is in the Details! Is Prophylactic HIPEC and Cytoreduction the New Standard of Care for T4 Colorectal Cancer?
Ballal DS; Saklani AP
Indian J Surg Oncol; 2024 Jun; 15(2):302-303. PubMed ID: 38741653
[No Abstract] [Full Text] [Related]
9. Re: "Strategy for the practice of digestive and oncologic surgery in COVID-19 epidemic situation". As regards the detection of coronavirus in peritoneal fluid.
Drissi F; Frey S; Abet E
J Visc Surg; 2021 Feb; 158(1):96-97. PubMed ID: 33268321
[No Abstract] [Full Text] [Related]
10. How Context Matters: A Dissemination and Implementation Primer for Global Oncologists.
Koczwara B; Birken SA; Perry CK; Cragun D; Zullig LL; Ginossar T; Nodora J; Chawla N; Ramanadhan S; Kerner J; Brownson RC
J Glob Oncol; 2016 Apr; 2(2):51-55. PubMed ID: 28717683
[No Abstract] [Full Text] [Related]
11. Erratum to: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
van Vugt JL; Braam HJ; van Oudheusden TR; Vestering A; Bollen TL; Wiezer MJ; de Hingh IH; van Ramshorst B; Boerma D
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1610. PubMed ID: 25791788
[No Abstract] [Full Text] [Related]
12. Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only.
Désolneux G; Mazière C; Vara J; Brouste V; Fonck M; Béchade D; Bécouarn Y; Evrard S
PLoS One; 2015; 10(3):e0122816. PubMed ID: 25825874
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands.
van Oudheusden TR; Lemmens VE; Braam HJ; van Ramshorst B; Meijerink J; te Velde EA; Mehta AM; Verwaal VJ; de Hingh IH
Surgery; 2015 Jun; 157(6):1023-7. PubMed ID: 25818658
[TBL] [Abstract][Full Text] [Related]
14. Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.
Dubé P; Sideris L; Law C; Mack L; Haase E; Giacomantonio C; Govindarajan A; Krzyzanowska MK; Major P; McConnell Y; Temple W; Younan R; McCart JA
Curr Oncol; 2015 Apr; 22(2):e100-12. PubMed ID: 25908915
[TBL] [Abstract][Full Text] [Related]
15. Protein trafficking in colorectal carcinogenesis-targeting and bypassing resistance to currently applied treatments.
Gargalionis AN; Karamouzis MV; Adamopoulos C; Papavassiliou AG
Carcinogenesis; 2015 Jun; 36(6):607-15. PubMed ID: 25863128
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oxaliplatin-based chemotherapy + bevacizumab as first-line treatment for advanced colorectal cancer: a systematic review and pooled analysis of published trials.
Petrelli F; Coinu A; Ghilardi M; Cabiddu M; Zaniboni A; Barni S
Am J Clin Oncol; 2015 Apr; 38(2):227-33. PubMed ID: 25806713
[TBL] [Abstract][Full Text] [Related]
17. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy.
Moran B; Cecil T; Chandrakumaran K; Arnold S; Mohamed F; Venkatasubramaniam A
Colorectal Dis; 2015 Sep; 17(9):772-8. PubMed ID: 25880479
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90.
Zunino B; Rubio-Patiño C; Villa E; Meynet O; Proics E; Cornille A; Pommier S; Mondragón L; Chiche J; Bereder JM; Carles M; Ricci JE
Oncogene; 2016 Jan; 35(2):261-8. PubMed ID: 25867070
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy at a tertiary care center: initial experience.
Clemente-Gutiérrez U; Garza-Gangemi A; Trejo-Gómez G; Medina-Franco H
Rev Invest Clin; 2015; 67(1):39-45. PubMed ID: 25857583
[TBL] [Abstract][Full Text] [Related]
20. Respiratory distress due to malignant ascites palliated by hyperthermic intraperitoneal chemotherapy.
van den Houten MM; van Oudheusden TR; Luyer MD; Nienhuijs SW; de Hingh IH
World J Gastrointest Surg; 2015 Mar; 7(3):39-42. PubMed ID: 25848491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
